Takeda

VPRIV

  1. Home
  2.  / 
  3. J Code
  4.  / VPRIV – J3385

Manufacturer:

Takeda

Name:

VPRIV

HCPCS Code Descriptor:

Injection, velaglucerase alfa, 100 units

Category:

J Code

HCPCS:

J3385

NDC(s):

54092-0701-04

Primary Type:

Enzyme Replacement Therapy

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

VPRIV is an Enzyme Replacement Therapy drug manufactured by Takeda and administered via the Intravenous route of administration. The J Code: J3385 is aligned to the drug VPRIV.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/11

HCPCS Effective Date:

1/1/11

HCPCS Short Description:

Velaglucerase alfa

Billing and Coding Guide:

https://www.hcp.vpriv.com/Contents/PDF/VPRIV%20Reimbursment%20Flyer.pdf

Patient Assistance:

Not Found